Tag: autoantibody

1. In relatives of patients with type 1 diabetes (T1DM) at risk for disease development, randomization to teplizumab delayed time to T1DM diagnosis compared to placebo treated patients. 2. Adverse events associated with teplizumab treatment included rash and transient lymphopenia. Evidence Rating Level: 1 (Excellent)   Study Rundown: T1DM results from autoimmune destruction...
1. In relatives of patients with type 1 diabetes (T1DM) at risk for disease development, randomization to teplizumab delayed time to T1DM diagnosis compared to placebo treated patients. 2. Adverse events associated with teplizumab treatment included rash and transient lymphopenia. Evidence Rating Level: 1 (Excellent)   Study Rundown: T1DM results from autoimmune...